Languido, Mayla .

HRN: 18-51-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2023
CEFUROXIME 1.5GM (VIAL)
02/04/2023
02/04/2023
IV
1 Vial
On Call To Or
Stat CS
Waiting Final Action 
02/04/2023
CEFUROXIME 1.5GM (VIAL)
02/04/2023
02/05/2023
IVT
1.5 Gms
Q8 X 3 Doses
LTCS
Waiting Final Action 
02/05/2023
CEFUROXIME 500MG (TAB)
02/05/2023
02/11/2023
ORAL
500mg
BID
S/P Cesarean
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: